FACTANKER · measured, cited, anchored official records connected

Call report 2026Q2 · Schedule RC-B

BANK OF AMERICA, NATIONAL ASSOCIATION — Schedule RC-B — Securities, 2026Q2

The securities portfolio by type — Treasuries, agency debt, mortgage-backed securities, municipal and corporate bonds — each at amortized cost and fair value, split into held-to-maturity and available-for-sale.

PERIOD: 2026Q2SOURCE: FFIEC Call Report, RCB152 items, each source-linked

Cite: FACTANKER, https://factanker.com/entity/9f2202a4-e698-41c8-b2aa-422d8f10e40b/2026Q2/rc-b

What stands out

BANK OF AMERICA, NATIONAL ASSOCIATION filed 152 items on Schedule RC-B for 2026Q2. The largest amount is $505.82B for “Held-to-maturity Securities”, 19.1 % of total assets. Next come “Held-to-maturity Securities” at $505.82B and “Totl Secs-held-to-matrty-fair Value” at $423.73B. 61 of the 152 items are reported as zero — the line exists on the form, the bank has no such position. Dollar amounts are as filed, in thousands of USD; counts, dates and ratios keep their own units. Every value links to its fact record with the filing it came from.

Schedule RC-B — Securities

The securities portfolio by type — Treasuries, agency debt, mortgage-backed securities, municipal and corporate bonds — each at amortized cost and fair value, split into held-to-maturity and available-for-sale.

ItemMDRMValue as filedSource
US Treas Secs-hld-to-mat-amrtz CostRCFD0211121,262,000evidence →
US Treas Secs-hld-to-mat-fair ValueRCFD0213108,251,000evidence →
Pledged Securities-book VlaueRCFD0416162,486,000evidence →
US Treas Secs-avl-for-sle-amrtz CostRCFD1286177,651,000evidence →
US Treas Secs-avl-for-sle-fair ValueRCFD1287176,993,000evidence →
Othr Domstc Debt Secs-hld-to-mat-amrRCFD1737140,000evidence →
Othr Domstc Debt Secs-hld-to-mat-faiRCFD1738134,000evidence →
Othr Domstc Debt Secs-avl-fr-sle-amrRCFD17393,852,000evidence →
Othr Domstc Debt Secs-avl-fr-sle-faiRCFD17413,851,000evidence →
Fgn Debt Secs-held-to-matr-amrtz CosRCFD17420evidence →
Fgn Debt Secs-held-to-matr-fair ValuRCFD17430evidence →
Fgn Debt Secs-avl-for-sale-amrtz CosRCFD174417,842,000evidence →
Fgn Debt Secs-avl-for-sale-fair ValuRCFD174617,809,000evidence →
Held-to-maturity SecuritiesRCFD1754505,819,000evidence →
Totl Secs-held-to-matrty-fair ValueRCFD1771423,726,000evidence →
Totl Secs-avl-for-sale-amrtz CostRCFD1772331,094,000evidence →
Amrtz Cost Of Hld-to-mat Secs SoldRCFD17780evidence →
Secs Issd By US St&pol Subdys-amrtzRCFD84968,000evidence →
Secs Issd By US St&pol Subdys-fairRCFD84978,000evidence →
Secs Issd By US St&pol Subdys-amrtzRCFD84984,045,000evidence →
Secs Issd By US St&pol Subdys-fairRCFD84994,015,000evidence →
Amortized Cost Of Structured NotesRCFD87820evidence →
Fair Value Of Structured NotesRCFD87830evidence →
Fxd&fltg Rt Debt Secs Mat 1 Yr Or LeRCFDA24829,492,000evidence →
Secs Isd By US Treas,etc 3 Mos LessRCFDA54942,054,000evidence →
Secs Isd By US Treas,etc Ov 3-12 MosRCFDA55020,891,000evidence →
Secs Isd By US Treas,etc Ov 1-3 YrsRCFDA551129,171,000evidence →
Secs Isd By US Treas,etc Ov 3-5 YrsRCFDA552164,057,000evidence →
Secs Isd By US Treas,etc Ov 5-15 YrsRCFDA55334,295,000evidence →
Secs Isd By US Treas,etc Over 15 YrsRCFDA554222,000evidence →
Mtge Pass-thru Secs Mat 3 Months LesRCFDA5550evidence →
Mtge Pass-thru Secs Mat Ov 3-12 MthsRCFDA5560evidence →
Mtge Pass-thru Secs Mat Ov 1 - 3 YrsRCFDA5572,000evidence →
Mtge Pass-thru Secs Mat Ov 3 - 5 YrsRCFDA5582,000evidence →
Mtge Pass-thru Secs Mat Ov 5 - 15 YrRCFDA5596,600,000evidence →
Mtge Pass-thru Secs Mat Over 15 YearRCFDA560411,820,000evidence →
Other Mtg-bckd Secs 3 Years Or LessRCFDA5612,016,000evidence →
Other Mtg-bckd Secs Over 3 YearsRCFDA56223,702,000evidence →
Htm(cost): ABS - Credit Card ReceivRCFDB8380evidence →
Htm(fair): ABS - Credit Card ReceivRCFDB8390evidence →
Afs(cost): ABS - Credit Card ReceivRCFDB840962,000evidence →
Afs(fair): ABS - Credit Card ReceivRCFDB841959,000evidence →
Htm(cost): ABS - Home Equity LinesRCFDB8420evidence →
Htm(fair): ABS - Home Equity LinesRCFDB8430evidence →
Afs(cost): ABS - Home Equity LinesRCFDB8440evidence →
Afs(fair): ABS - Home Equity LinesRCFDB8450evidence →
Htm(cost): ABS - Automobile LoansRCFDB8460evidence →
Htm(fair): ABS - Automobile LoansRCFDB8470evidence →
Afs(cost): ABS - Automobile LoansRCFDB8485,624,000evidence →
Afs(fair): ABS - Automobile LoansRCFDB8495,610,000evidence →
Htm(cost): Abs- Other Consumer LoansRCFDB8500evidence →
Htm(fair): Abs- Other Consumer LoansRCFDB8510evidence →
Afs(cost): Abs- Other Consumer LoansRCFDB8522,984,000evidence →
Afs(fair): Abs- Other Consumer LoansRCFDB8532,984,000evidence →
Htm(cost): Abs- Commrcial &ind LoansRCFDB8540evidence →
Htm(fair): Abs- Commrcial &ind LoansRCFDB8550evidence →
Afs(cost): Abs- Commrcial &ind LoansRCFDB856415,000evidence →
Afs(fair): Abs- Commrcial &ind LoansRCFDB857414,000evidence →
Htm(cost): Asset Backed Sec - OtherRCFDB8580evidence →
Htm(fair): Asset Backed Sec - OtherRCFDB8590evidence →
Afs(cost): Asset Backed Sec - OtherRCFDB8605,175,000evidence →
Afs(fair): Asset Backed Sec - OtherRCFDB8615,164,000evidence →
Htm(cost):totl Asset-back Sec - DervRCFDC0260evidence →
Afs(fair):totl Asset-back Sec -dervRCFDC02715,131,000evidence →
Asset-backed Securities: Htm-fair VaRCFDC9880evidence →
Asset-backed Securities:afs-amtzd CoRCFDC98915,160,000evidence →
MBS Rpts Guar Gnma HTM AmrtzRCFDG30036,453,000evidence →
MBS Rpts Guar Gnma HTM FvRCFDG30131,856,000evidence →
MBS Rpts Guar Gnma AFS AmrtzRCFDG30233,925,000evidence →
MBS Rpts Guar Gnma AFS FvRCFDG30333,006,000evidence →
MBS Rpts Iss Fnma Fhlmc HTM AmrtzRCFDG304342,716,000evidence →
MBS Rpts Iss Fnma Fhlmc HTM FvRCFDG305278,981,000evidence →
MBS Rpts Iss Fnma Fhlmc AFS AmrtzRCFDG3066,563,000evidence →
MBS Rpts Iss Fnma Fhlmc AFS FvRCFDG3076,249,000evidence →
MBS Rpts Othr Pt Scty HTM Amrtz CostRCFDG3080evidence →
MBS Rpts Othr Pt Scty HTM FvRCFDG3090evidence →
MBS Rpts Othr Pt Scty AFS Amrtz CostRCFDG3100evidence →
MBS Rpts Othr Pt Scty AFS FvRCFDG3110evidence →
MBS Othr Res Iss Guar Ffg HTM AmrtzRCFDG3123,784,000evidence →
MBS Othr Res Iss Guar Ffg HTM FvRCFDG3133,177,000evidence →
MBS Othr Res Iss Guar Ffg AFS AmrtzRCFDG31417,204,000evidence →
MBS Othr Res Iss Guar Ffg AFS FvRCFDG31517,148,000evidence →
MBS Othr Res Cltrl Iss Guar Ffg HTMRCFDG3160evidence →
MBS Othr Res Cltrl Iss Guar Ffg H FvRCFDG3170evidence →
MBS Othr Res Cltrl Iss Guar Ffg AFSRCFDG3180evidence →
MBS Othr Cltrl MBS Iss Guar Ffg A FvRCFDG3190evidence →
MBS Othr Othr Res MBS HTM AmrtzRCFDG3200evidence →
MBS Othr Othr Res MBS HTM FvRCFDG3210evidence →
MBS Othr Othr Res MBS AFS AmrtzRCFDG3221,256,000evidence →
MBS Othr Othr Res MBS AFS FvRCFDG3231,252,000evidence →
Sfp Tps Iss Fnc Inst HTM Amrtz CostRCFDG3480evidence →
Sfp Tps Iss Fnc Inst HTM FvRCFDG3490evidence →
Sfp Tps Iss Fnc Inst AFS Amrtz CostRCFDG35020,000evidence →
Sfp Tps Iss Fnc Inst AFS FvRCFDG35120,000evidence →
Sfp Tps Iss RE Inv Tr HTM Amrtz CostRCFDG3520evidence →
Sfp Tps Iss RE Inv Trs HTM FvRCFDG3530evidence →
Sfp Tps Iss RE Inv Tr AFS Amrtz CostRCFDG3540evidence →
Sfp Tps Iss RE Inv Tr AFS FvRCFDG3550evidence →
Sfp Corp & Similar Ln HTM Amrtz CostRCFDG3560evidence →
Sfp Corp & Similar Ln HTM FvRCFDG3570evidence →
Sfp Corp & Similar Ln AFS Amrtz CostRCFDG3588,753,000evidence →
Sfp Corp & Similar Ln AFS FvRCFDG3598,752,000evidence →
Sfp 1t4 Res MBS I Or G Gse HTM AmrtzRCFDG3600evidence →
Sfp 1t4 Res MBS I Or G Gse HTM FvRCFDG3610evidence →
Sfp 1t4 Res MBS I Or G Gse AFS AmrtzRCFDG3620evidence →
Sfp 1t4 Res MBS I Or G Gse AFS FvRCFDG3630evidence →
Sfp 1t4 MBS N I Or G Gse HTM AmrtzRCFDG3640evidence →
Sfp 1t4 Res MBS N I Or G Gse HTM FvRCFDG3650evidence →
Sfp 1t4 MBS N I Or G Gse AFS AmrtzRCFDG3660evidence →
Sfp 1t4 Res MBS N I Or G Gse AFS FvRCFDG3670evidence →
Sfp Dvrs (mixed) Pools Sfp HTM AmrtzRCFDG3680evidence →
Sfp Dvrs (mixed) Pools Sfp HTM FvRCFDG3690evidence →
Sfp Dvrs (mixed) Pools Sfp AFS AmrtzRCFDG3700evidence →
Sfp Dvrs (mixed) Pools Sfp AFS FvRCFDG3710evidence →
Sfp Othr Cltrl Ref Asset HTM AmrtzRCFDG372315,000evidence →
Sfp Othr Cltrl Ref Asset HTM FvRCFDG373285,000evidence →
Sfp Othr Cltrl Ref Asset AFS AmrtzRCFDG37412,399,000evidence →
Sfp Othr Cltrl Ref Asset AFS FvRCFDG37512,399,000evidence →
US government agency obligations (exRCFDHT500evidence →
US government agency obligations (exRCFDHT510evidence →
US government agency obligations (exRCFDHT5230,000evidence →
US government agency obligations (exRCFDHT5329,000evidence →
Asset-backed securities and structurRCFDHT58315,000evidence →
Asset-backed securities and structurRCFDHT59285,000evidence →
Asset-backed securities and structurRCFDHT6021,172,000evidence →
Asset-backed securities and structurRCFDHT6121,171,000evidence →
MBS Cmrl Pt Scty Guar Fnma HTM AmtrzRCFDK142133,000evidence →
MBS Cmrl Pt Scty Guar Fnma HTM FvRCFDK143130,000evidence →
MBS Cmrl Pt Scty Guar Fnma AFS AmtrzRCFDK14430,072,000evidence →
MBS Cmrl Pt Scty Guar Fnma AFS FvRCFDK14529,833,000evidence →
MBS Cmrl Pt Scty Othr HTM AmtrzRCFDK1460evidence →
MBS Cmrl Pt Scty Othr HTM FvRCFDK1470evidence →
MBS Cmrl Pt Scty Othr AFS AmtrzRCFDK1480evidence →
MBS Cmrl Pt Scty Othr AFS FvRCFDK1490evidence →
MBS Cmrl Othr Cmrl Guar Fnma HTM AmtRCFDK1500evidence →
MBS Cmrl Othr Cmrl Guar Fnma HTM FvRCFDK1510evidence →
MBS Cmrl Othr Cmrl Guar Fnma AFS AmtRCFDK1522,035,000evidence →
MBS Cmrl Othr Cmrl Guar Fnma AFS FvRCFDK1531,904,000evidence →
MBS Cmrl Othr Cmrl Othr Cmrl HTM AmtRCFDK1541,008,000evidence →
MBS Cmrl Othr Cmrl Othr Cmrl HTM FvRCFDK155904,000evidence →
MBS Cmrl Othr Cmrl Othr Cmrl AFS AmtRCFDK156636,000evidence →
MBS Cmrl Othr Cmrl Othr Cmrl AFS FvRCFDK157622,000evidence →
Amortized cost of available-for-saleRCFDMG95-349,000evidence →
Structured financial products guaranRCFDPU98315,000evidence →
Structured financial products guaranRCFDPU99285,000evidence →
Structured financial products guaranRCFDPV0012,400,000evidence →
Structured financial products guaranRCFDPV0112,399,000evidence →
US Treas Secs-hld-to-mat-amrtz CostRCON0211121,262,000evidence →
US Treas Secs-avl-for-sle-fair ValueRCON1287176,943,000evidence →
Held-to-maturity SecuritiesRCON1754505,819,000evidence →
Secs Issd By US St&pol Subdys-amrtzRCON84968,000evidence →
Secs Issd By US St&pol Subdys-fairRCON84994,015,000evidence →

Other schedules of this call report

31 further schedules filed by BANK OF AMERICA, NATIONAL ASSOCIATION for 2026Q2.

Machine access — free, no API key

Every figure shown here about BANK OF AMERICA, NATIONAL ASSOCIATION — Schedule RC-B, 2026Q2 can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.

These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.